Navigation Links
PTC124 shows activity in cystic fibrosis; Phase 2 proof-of-concept data published in Lancet
Date:8/20/2008

SOUTH PLAINFIELD, NJ August 20, 2008 New phase 2 data published today in The Lancet show that the investigational oral drug PTC124 demonstrates activity in nonsense-mutation cystic fibrosis (CF). The data show that treatment with PTC124 results in statistically significant improvements in the chloride channel function of patients with nonsense-mutation CF. The study was conducted at the Hadassah Hebrew University Hospital in Jerusalem, Israel and sponsored by PTC Therapeutics (PTC).

Patients with CF lack adequate levels of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, a chloride channel which is required for normal function of the lung, pancreas, liver, and other organs. Nonsense mutations are single-point alterations in the genetic code that prematurely stop the translation process, preventing production of a full-length, functional protein. Patients with nonsense-mutation CF generally make virtually no CFTR protein and thus often have a more severe form of CF. By inducing the production of functional CFTR, PTC124 is addressing the underlying genetic defect responsible for CF. Nonsense mutations are responsible for approximately 10 percent of the cases of cystic fibrosis worldwide. However, in Israel, nonsense mutations are responsible for the majority of CF cases.

STUDY RESULTS: PTC124 RESTORED FUNCTIONAL PRODUCTION OF CFTR PROTEIN IN PATIENTS

This Phase 2 Israeli study enrolled 23 adult patients (median age 25 years) with nonsense-mutation CF. More than 90 percent of patients had severe CF with compromised lung function, pulmonary infection with Pseudomonas or other pathogenic bacteria, and pancreatic insufficiency. Patients were assessed in two 14-day treatment courses of oral PTC124 therapy, the first given at a lower dose and the second given at a higher dose. Results showed that at both dose levels, treatment with PTC124 was associated with statistically significant improv
'/>"/>

Contact: Jane Baj
jbaj@ptcbio.com
908-912-9167
Pure Communications Inc.
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related biology news :

1. Analysis of Lake Washington microbes shows the power of metagenomic approaches
2. Light receptors in eye play key role in setting biological clock, study shows
3. Study shows continued spread of dead zones
4. Duke-NIEHS team shows how DNA repairs may reshape the genome
5. Nano vaccine for hepatitis B shows promise for third world
6. Experimental chemotherapy regimen shows promise in treating advanced lung cancer
7. New breastfeeding study shows most moms quit early
8. When our protective armor shows weakness
9. Lab study shows methadone breaks resistance in untreatable forms of leukemia
10. Immunotherapy in high-risk pediatric sarcomas shows promising response
11. New study shows compounds from soy affect brain and reproductive development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2013)... difficulty understanding and explaining how evolution operates. In ... researchers at Michigan State University developed complete evolutionary ... changes underlying an evolving characteristic to their genetic ... J. T. White, Merle K. Heidemann, and James ... into a cellular and molecular biology course taught ...
(Date:6/14/2013)... of the diversity of species in every ecosystem. Despite ... of food webs. If parasites play different roles from ... alter our understanding of how food webs are organized. ... week, Santa Fe Institute Professor Jennifer Dunne and collaborators ... ecological datasets does alter the structure of food webs, ...
(Date:6/14/2013)... years ago was very different from the one we swim ... marine food webs. Nitrogen run-off from fertilizers is causing coastal ... the first global study of changes that occurred in a ... end of the last ice age. The results of their ... cycle on a global scale. But the data also shows ...
Breaking Biology News(10 mins):Teaching complete evolutionary stories increases learning 2Does including parasites upset food web theory? Yes and no, says new paper 2Study of oceans' past raises worries about their future 2
... 2012)Nighttime visits to the bathroom are generally associated with ... problem can affect youngsters, too. A new study sheds ... more often during the rest cycle. Danish researchers have ... ages of eight and twelve, to urinate significantly more ...
... photograph of a polar bear in captivity, no matter ... about behavior as footage of that polar bear in ... can prove even more elusive. Limitations in biomedical imaging ... behavior, with biologists trying to envision dynamic processes through ...
... Singapore,s (GIS) Associate Director of Genomic Technologies, Dr Yijun ... spatial/structural configuration, revealing how genes interact/communicate and influence each ... each other. This discovery is crucial in understanding how ... how transcription regulation and coordination takes place in human ...
Cached Biology News:Sleep deprivation tied to increased nighttime urination in preadolescence 2New technology allows scientists to watch cancer cells in action at unprecedented resolution 2Singapore scientists lead in 3D mapping of human genome to help understand human diseases 2
(Date:6/17/2013)... As a leader in the skincare industry, the team at ... acne, rosacea, and eczema. As part of Acne and Rosacea ... Society) has dedicated a month to creating awareness about these ... treatment options. Probiotic Action follows in the footsteps of the ... social networks and online resources for the acne and rosacea ...
(Date:6/17/2013)... NEW YORK , June 17, 2013 /PRNewswire-iReach/ -- ... imaging techniques and other studies to explore the neurophysiological ... the impact of life experience such as bullying and ... Ten researchers will present their latest findings at ... in Scottsdale, AZ. More than ...
(Date:6/17/2013)... The ALS Therapy Development Institute (ALS TDI) ... charity cycling event on July 19-21, 2013. The Tri-State Trek is ... to Greenwich, CT with the ... Gehrig,s disease). (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO ) ... Tri-State Trek passes through 46 communities and includes 12 ...
(Date:6/17/2013)... 2013 Yongye International, Inc. (NASDAQ:   YONG) ... distributor of crop nutrient products in the ... that its common stock will resume trading on the ... 7:15 a.m. Eastern Time. As previously disclosed, ... March 18, 2013 following Yongye,s notification that the filing ...
Breaking Biology Technology:Acne and Rosacea Awareness Month: Probiotic Action Announces their Daily News Updates with Insight on the Most Common Skin Conditions 2New Research On Stuttering Jul 2-3 At Arizona Symposium 2New Research On Stuttering Jul 2-3 At Arizona Symposium 3ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 2ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 2Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 4
... 27 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ... Chief Executive Officer, will present at the 5th Annual ... September 28, 2010, at 10:30 a.m. Eastern Time. ... presentations will be accessible by visiting the Oncothyreon website ...
... Experience in STEMI Patients.... -- WASHINGTON, September 24, 2010 ... ... ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
... GeneLink BioSciences, Inc. (OTC Bulletin Board: GNLK, ... www.helixlife.com ), a private label distribution partnership serving the ... CEO, stated, "HelixLife gives GeneLink reach into new areas ... have not been available to us.  The HelixLife team ...
Cached Biology Technology:InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today. 2InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today. 3InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today. 4InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today. 5InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today. 6InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today. 7GeneLink Announces HelixLife Private Label Distribution Agreement 2
GLP expression profiling service on the Affymetrix platform. Starting material can be blood, tissue or RNA. 5 day turnaround. Standard and custom post analyses of microarray data available....
... 3096 Microplate Luminometer has been designed,for ... and for,all measurements of glow and ... where the light remain nearly constant,over ... well as for very fast reactions,requiring ...
... 2-3x faster than western blotting. Get results sooner ... Direct on gel detection. Eliminates the need for ... methods. All reagents are ready-to-use. No reagents ... use. Only 2 reagents required. Guarantees a simple ...
... Deletion Machine is based on the simple, ... by Goryshin and Reznikoff, and by York ... of deletions and inversions by intramolecular transposition ... plasmid vector. Although most researchers will be ...
Biology Products: